Marine Drugs · 2019 · 10 citations · 27 references
Life SciencesCell BiologyPharmacologyApoptosisCancer PharmacologyCell SignalingApoptosis In CancerApoptosis ModulationApoptosis RegulationMarine Bioactive CompoundsMarine Drug DiscoveryMarine PharmacologyApoptosis Regulation By KinasesBioactive Marine MetabolitesMarine Sponge MetabolitesMarine-derived Anticancer CompoundsMitotic Index ReductionNecroptotic SignalingPharmacological ScreeningSignal Transduction Mechanisms
Regulated cell death (RCD) results from the activation of one or more signal transduction modules both in physiological or pathological conditions. It is now established that RCD is involved in numerous human diseases, including cancer. As regulated cell death processes can be modulated by pharmacological tools, the research reported here aims to characterize new marine compounds acting as RCD modulators. Protein kinases (PKs) are key signaling actors in various RCDs notably through the control of either mitosis (e.g., the PKs Aurora A and B) or necroptosis (e.g., RIPK1 and RIPK3). From the primary screening of 27 various extracts of marine organisms collected in the Mediterranean Sea, an extract and subsequently a purified high molecular weight compound dubbed P3, were isolated from the marine sponge Crambe tailliezi and characterized as a selective inhibitor of PKs Aurora A and B. Furthermore, P3 was shown to induce apoptosis and to decrease proliferation and mitotic index of human osteosarcoma U-2 OS cells.
27
Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
Scott J. Dixon, Kathryn M. Lemberg, Michael R. Lamprecht et al. · Cell · 2012 · 18.1K citations · Full text
I. Vermes, C. Haanen, H M Steffens-Nakken et al. · Journal of Immunological Methods · 1995 · 5.4K citations · Full text